Ken Fisher's ALNY Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 6,252 shares of Alnylam Pharmaceuticals, Inc. (ALNY) worth $1.88 M, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Ken Fisher has initiated a new position in ALNY, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 207 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Alnylam Pharmaceuticals (ALNY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Alnylam Pharmaceuticals (ALNY) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +207 | Add 3.42% | 6,252 | $301.04 |
| Q1 2026 | +6,045 | New Buy | 6,045 | $330.91 |
Ken Fisher's Alnylam Pharmaceuticals Investment FAQs
Ken Fisher first purchased Alnylam Pharmaceuticals, Inc. (ALNY) in Q1 2026, acquiring 6,045 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Alnylam Pharmaceuticals, Inc. (ALNY) for 2 quarters since Q1 2026.
Ken Fisher's largest addition to Alnylam Pharmaceuticals, Inc. (ALNY) was in Q1 2026, adding 6,045 shares worth $2 M.
According to the latest 13F filing for Q2 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 6,252 shares of Alnylam Pharmaceuticals, Inc. (ALNY), valued at approximately $1.88 M.
As of the Q2 2026 filing, Alnylam Pharmaceuticals, Inc. (ALNY) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Alnylam Pharmaceuticals, Inc. (ALNY) was 6,252 shares, as reported at the end of Q2 2026.